Literature DB >> 35190684

Immunometabolism at the intersection of metabolic signaling, cell fate, and systems immunology.

Hongbo Chi1.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35190684      PMCID： PMC8891332          DOI： 10.1038/s41423-022-00840-x

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN： 1672-7681            Impact factor:   22.096


× No keyword cloud information.
  3 in total

Review 1.  Metabolic Reprogramming of Innate Immune Cells as a Possible Source of New Therapeutic Approaches in Autoimmunity.

Authors:  Leila Mohammadnezhad; Mojtaba Shekarkar Azgomi; Marco Pio La Manna; Guido Sireci; Chiara Rizzo; Giusto Davide Badami; Bartolo Tamburini; Francesco Dieli; Giuliana Guggino; Nadia Caccamo
Journal:  Cells       Date:  2022-05-17       Impact factor: 7.666

2.  Metabolic heterogeneity caused by HLA-DRB1*04:05 and protective effect of inosine on autoimmune hepatitis.

Authors:  Fan Yang; Leyu Zhou; Yi Shen; Shenglan Zhao; Yanyi Zheng; Ruoting Men; Xiaoli Fan; Li Yang
Journal:  Front Immunol       Date:  2022-08-05       Impact factor: 8.786

Review 3.  New Developments in T Cell Immunometabolism and Therapeutic Implications for Type 1 Diabetes.

Authors:  Mengdi Zhang; Yanyan Zhou; Zhiguo Xie; Shuoming Luo; Zhiguang Zhou; Jiaqi Huang; Bin Zhao
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-10       Impact factor: 6.055
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.